SE419500B - Forfarande for attenuering av ett koronavirusliknande kalvdiarrevirus for framstellning av kalvdiarrevaccin - Google Patents

Forfarande for attenuering av ett koronavirusliknande kalvdiarrevirus for framstellning av kalvdiarrevaccin

Info

Publication number
SE419500B
SE419500B SE7314001A SE7314001A SE419500B SE 419500 B SE419500 B SE 419500B SE 7314001 A SE7314001 A SE 7314001A SE 7314001 A SE7314001 A SE 7314001A SE 419500 B SE419500 B SE 419500B
Authority
SE
Sweden
Prior art keywords
revirus
diarvaccin
calvdar
calv
attenuation
Prior art date
Application number
SE7314001A
Other languages
English (en)
Inventor
C A Mebus
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nebraska filed Critical Univ Nebraska
Publication of SE419500B publication Critical patent/SE419500B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7314001A 1972-10-30 1973-10-16 Forfarande for attenuering av ett koronavirusliknande kalvdiarrevirus for framstellning av kalvdiarrevaccin SE419500B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30217972A 1972-10-30 1972-10-30

Publications (1)

Publication Number Publication Date
SE419500B true SE419500B (sv) 1981-08-10

Family

ID=23166611

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7314001A SE419500B (sv) 1972-10-30 1973-10-16 Forfarande for attenuering av ett koronavirusliknande kalvdiarrevirus for framstellning av kalvdiarrevaccin

Country Status (17)

Country Link
JP (3) JPS5817169B2 (sv)
AR (1) AR200155A1 (sv)
AU (1) AU476160B2 (sv)
BE (1) BE806568A (sv)
CA (1) CA1019675A (sv)
CH (1) CH596315A5 (sv)
DD (1) DD110517A5 (sv)
DE (1) DE2354324C2 (sv)
ES (1) ES419996A1 (sv)
FI (1) FI52740C (sv)
FR (1) FR2204405B1 (sv)
GB (1) GB1401565A (sv)
HU (1) HU168486B (sv)
IE (1) IE38423B1 (sv)
NL (1) NL7314293A (sv)
SE (1) SE419500B (sv)
ZA (1) ZA738329B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027007U (ja) * 1983-07-30 1985-02-23 株式会社　協立双葉自動機 容器回転速度調整装置付きラベリングマシン
JPH0518338Y2 (sv) * 1985-12-27 1993-05-17
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
GB8818415D0 (en) * 1988-08-03 1988-09-07 Animal Health Inst Vaccine
JPH08786B2 (ja) * 1993-02-25 1996-01-10 株式会社微生物化学研究所 牛コロナウイルス感染症ワクチン
EP3372677B8 (en) 2015-11-06 2019-09-25 Asahi Kasei Medical Co., Ltd. Method for producing parvovirus having high infectivity titer and high purity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759425A (fr) * 1969-11-28 1971-05-25 Mebus Charles A Vaccins contre la diarrhee du veau, leur preparation et emploi
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same

Also Published As

Publication number Publication date
AU476160B2 (en) 1976-09-16
IE38423L (en) 1974-04-30
CA1019675A (en) 1977-10-25
DE2354324A1 (de) 1974-05-09
GB1401565A (en) 1975-07-16
FR2204405A1 (sv) 1974-05-24
AU6177473A (en) 1975-04-24
ES419996A1 (es) 1976-08-01
JPS5531058A (en) 1980-03-05
JPS6124370B2 (sv) 1986-06-10
CH596315A5 (sv) 1978-03-15
JPS5757449B2 (sv) 1982-12-04
BE806568A (fr) 1974-04-26
JPS5817169B2 (ja) 1983-04-05
IE38423B1 (en) 1978-03-15
FR2204405B1 (sv) 1977-01-28
JPS4980230A (sv) 1974-08-02
DD110517A5 (sv) 1974-12-20
HU168486B (en) 1976-05-28
DE2354324C2 (de) 1982-06-03
JPS57131726A (en) 1982-08-14
NL7314293A (sv) 1974-05-02
FI52740B (sv) 1977-08-01
AR200155A1 (es) 1974-10-24
FI52740C (sv) 1977-11-10
ZA738329B (en) 1974-09-25

Similar Documents

Publication Publication Date Title
NO140556C (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
FI65459B (fi) Foerfarande och anordning foer framstaellning av en foerskummad fibersuspension
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE7604260L (sv) Forfarande for isolering av ap-glykoproteiner
SE399064B (sv) Forfarande for framstellning av ett nytt dopaminderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
NO140478C (no) Fremgangsmaate for fremstilling av fibriller
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
BG21028A3 (bg) Метод за получаване на амино-бензимидазоли
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE419500B (sv) Forfarande for attenuering av ett koronavirusliknande kalvdiarrevirus for framstellning av kalvdiarrevaccin
BG22816A3 (bg) Метод за получаване на 2-алкиламино-дихидропиридини
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
BG20595A3 (bg) Методл за получаване на n-бензхидрил n-р-хидроксилбензил-пиперазини
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE416952B (sv) Forfarande for framstellning av substituerade fenylamidinokarbamidforeningar
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner